Category: Funding Roundup
Gynesonics pulls in $3 million in a new debt financing that will help fuel further development of its VizAblate fibroid treatment device.
California's Gynesonics reported raising $3 million in a new debt offering as it pursues development of its VizAblate fibroid treatment device.
Here's a look at some of the top legal news stories for medical device companies this week: Medtech investment in Minnesota falls back to earth; Tal Medical raises $14m for non-invasive anti-depression device; CSA Medical raises another $4m for cryotherapy device; Spirox lands $19m Series B round
, Aperture Venture Partners
, Correlation Ventures
, CSA Medical Inc.
, LifeScience Alley
, Osprey Medical
, Sunshine Heart Inc.
, Tal Medical
, Western Technology Investment
Spirox says it landed a nearly $19 million Series B round for its anti-nasal obstruction device.
Spirox said this week that it nailed down an $18.5 million Series B round to back development and commercialization of its device to treat patients with nasal obstructions.
Venrock and Aisling Capital led the round for Menlo Park, Calif.-based Spirox, with existing investors Aperture Venture Partners, Correlation Ventures and Western Technology Investment also participating.
Tal Medical says it raised $14 million for its low-field magnetic stimulation technology, which is designed to be a non-invasive treatment for depression and bipolar disorder.
Tal Medical said today that it landed a $14 million Series B round it plans to use in backing clinical trials for its low-field magnetic stimulation technology as a non-invasive neurostimulation treatment for depression and bipolar disorder.
Cryotherapy device maker CSA Medical raises nearly $3 million of a planned $3.9 million debt offering.
Maryland's CSA Medical said last week that it's close to reaching a $4 million funding goal with a new debt offering.
First-quarter investment in Minnesota's thriving medtech cluster falls back to earth after exploding off the charts last year.
After an off-the-charts year in investment for 2014, the Minnesota bioscience industry has seen a more typical 1st quarter, according to a report from medtech lobby LifeScience Alley.
Here's a look at some of the top legal news stories for medical device companies this week: EBR Systems raises $20m for wireless pacer; ReCor Medical raises $15M for ultrasound RDN; LVADs: Leviticus Cardio raises $1.5m for wireless power tech; Medtronic gets in on $10m Series C for Ortho Kinematics; Clear Guide Medical nabs $1.5M NIH grant for ultrasound-guided procedures